FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116639849> ?p ?o ?g. }

• W2116639849 endingPage "1368" @default.
• W2116639849 startingPage "1362" @default.
• W2116639849 abstract "We developed clinically relevant genotypic scores for resistance to fosamprenavir/ritonavir in HIV-1 protease inhibitor (PI)-experienced patients.PI-experienced patients with virological failure receiving fosamprenavir/ritonavir as the sole PI for at least 3 months and with detectable fosamprenavir plasma levels were included. The impact of baseline protease mutations on virological response (VR, i.e. decrease in plasma HIV-1 RNA between baseline and month 3) was analysed using the Mann-Whitney test. Mutations with prevalence >10% and P value <0.10 were retained. The Jonckheere-Terpstra test was used to select the combination of mutations most strongly associated with VR. The association between score and VR was assessed by multivariate backward regression.In the 73 patients included, the median baseline HIV-1 RNA was 4.6 log(10) copies/mL (range: 2.7-6.9) and the mean decrease at month 3 was -1.07 +/- 1.40 log(10) copies/mL. Ninety per cent of the patients were infected by HIV-1 subtype B variants. Two fosamprenavir/ritonavir mutation scores were constructed: score A (L10F/I/V + L33F + M36I + I54L/M/V/A/T/S + I62V + V82A/F/C/G + I84V + L90M) was based only on mutations associated with a worse VR, whereas score B (L10FIV + L33F + M36I + I54L/M/V/A/T/S + A71V - V77I - N88S + L90M) also took into account favourable mutations. Both scores were independent predictors of VR, however, co-administration of tenofovir was associated with a worse VR and the presence of the N88S protease mutation and co-administration of enfuvirtide with a better VR.These clinically validated mutation scores should be of interest for the clinical management of PI-experienced patients. The fosamprenavir/ritonavir score A was introduced in the 2006 ANRS algorithm along with isolated mutations I50V and V32I + I47V." @default.
• W2116639849 created "2016-06-24" @default.
• W2116639849 creator A5000901762 @default.
• W2116639849 creator A5009656834 @default.
• W2116639849 creator A5029948764 @default.
• W2116639849 creator A5039272561 @default.
• W2116639849 creator A5043721868 @default.
• W2116639849 creator A5047124634 @default.
• W2116639849 creator A5055564889 @default.
• W2116639849 creator A5056304668 @default.
• W2116639849 creator A5057397618 @default.
• W2116639849 creator A5059367621 @default.
• W2116639849 creator A5059602594 @default.
• W2116639849 creator A5059919084 @default.
• W2116639849 creator A5061527531 @default.
• W2116639849 creator A5070469805 @default.
• W2116639849 date "2008-03-13" @default.
• W2116639849 modified "2023-10-03" @default.
• W2116639849 title "Clinically validated mutation scores for HIV-1 resistance to fosamprenavir/ritonavir" @default.
• W2116639849 cites W1991872551 @default.
• W2116639849 cites W1994491237 @default.
• W2116639849 cites W2021877795 @default.
• W2116639849 cites W2040673826 @default.
• W2116639849 cites W2048835155 @default.
• W2116639849 cites W2055078358 @default.
• W2116639849 cites W2057749195 @default.
• W2116639849 cites W2061212708 @default.
• W2116639849 cites W2084487317 @default.
• W2116639849 cites W2109350540 @default.
• W2116639849 cites W2137947853 @default.
• W2116639849 cites W2144984387 @default.
• W2116639849 cites W2146646897 @default.
• W2116639849 cites W2165992764 @default.
• W2116639849 cites W2412239184 @default.
• W2116639849 cites W2419382823 @default.
• W2116639849 doi "https://doi.org/10.1093/jac/dkn127" @default.
• W2116639849 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18390885" @default.
• W2116639849 hasPublicationYear "2008" @default.
• W2116639849 type Work @default.
• W2116639849 sameAs 2116639849 @default.
• W2116639849 citedByCount "15" @default.
• W2116639849 countsByYear W21166398492012 @default.
• W2116639849 countsByYear W21166398492013 @default.
• W2116639849 countsByYear W21166398492017 @default.
• W2116639849 countsByYear W21166398492022 @default.
• W2116639849 crossrefType "journal-article" @default.
• W2116639849 hasAuthorship W2116639849A5000901762 @default.
• W2116639849 hasAuthorship W2116639849A5009656834 @default.
• W2116639849 hasAuthorship W2116639849A5029948764 @default.
• W2116639849 hasAuthorship W2116639849A5039272561 @default.
• W2116639849 hasAuthorship W2116639849A5043721868 @default.
• W2116639849 hasAuthorship W2116639849A5047124634 @default.
• W2116639849 hasAuthorship W2116639849A5055564889 @default.
• W2116639849 hasAuthorship W2116639849A5056304668 @default.
• W2116639849 hasAuthorship W2116639849A5057397618 @default.
• W2116639849 hasAuthorship W2116639849A5059367621 @default.
• W2116639849 hasAuthorship W2116639849A5059602594 @default.
• W2116639849 hasAuthorship W2116639849A5059919084 @default.
• W2116639849 hasAuthorship W2116639849A5061527531 @default.
• W2116639849 hasAuthorship W2116639849A5070469805 @default.
• W2116639849 hasBestOaLocation W21166398491 @default.
• W2116639849 hasConcept C104317684 @default.
• W2116639849 hasConcept C126322002 @default.
• W2116639849 hasConcept C135763542 @default.
• W2116639849 hasConcept C142462285 @default.
• W2116639849 hasConcept C156719811 @default.
• W2116639849 hasConcept C159047783 @default.
• W2116639849 hasConcept C182707283 @default.
• W2116639849 hasConcept C2522874641 @default.
• W2116639849 hasConcept C2779298103 @default.
• W2116639849 hasConcept C2781143361 @default.
• W2116639849 hasConcept C2993143319 @default.
• W2116639849 hasConcept C501734568 @default.
• W2116639849 hasConcept C54355233 @default.
• W2116639849 hasConcept C67705224 @default.
• W2116639849 hasConcept C71924100 @default.
• W2116639849 hasConcept C86803240 @default.
• W2116639849 hasConcept C90924648 @default.
• W2116639849 hasConceptScore W2116639849C104317684 @default.
• W2116639849 hasConceptScore W2116639849C126322002 @default.
• W2116639849 hasConceptScore W2116639849C135763542 @default.
• W2116639849 hasConceptScore W2116639849C142462285 @default.
• W2116639849 hasConceptScore W2116639849C156719811 @default.
• W2116639849 hasConceptScore W2116639849C159047783 @default.
• W2116639849 hasConceptScore W2116639849C182707283 @default.
• W2116639849 hasConceptScore W2116639849C2522874641 @default.
• W2116639849 hasConceptScore W2116639849C2779298103 @default.
• W2116639849 hasConceptScore W2116639849C2781143361 @default.
• W2116639849 hasConceptScore W2116639849C2993143319 @default.
• W2116639849 hasConceptScore W2116639849C501734568 @default.
• W2116639849 hasConceptScore W2116639849C54355233 @default.
• W2116639849 hasConceptScore W2116639849C67705224 @default.
• W2116639849 hasConceptScore W2116639849C71924100 @default.
• W2116639849 hasConceptScore W2116639849C86803240 @default.
• W2116639849 hasConceptScore W2116639849C90924648 @default.
• W2116639849 hasIssue "6" @default.
• W2116639849 hasLocation W21166398491 @default.
• W2116639849 hasLocation W21166398492 @default.

• next